Nicht lieferbar
"Liposomal Astaxanthin Protects Against Hepatocarcinoma" by V. Suganya is a comprehensive book that explores the potential of astaxanthin as a cytoprotective agent against liver cancer. The book presents research conducted on Swiss albino mice using diethylnitrosamine to induce hepatocarcinoma, and investigates the protective properties of astaxanthin, both encapsulated and non-encapsulated, against the disease. The book discusses the mechanisms of action of astaxanthin, such as its ability to scavenge free radicals and reduce oxidative stress, as well as its anti-inflammatory, apoptotic, and immunomodulatory properties. The encapsulation of astaxanthin in liposomes is explored in detail, with an emphasis on improving bioavailability and efficacy. The book highlights the importance of astaxanthin in preventing liver damage and inhibiting tumor growth, and its potential as a natural product and nutraceutical in cancer prevention and treatment. The book covers a range of topics related to hepatocarcinoma, such as hepatic injury, lipid peroxidation, histopathology, drug delivery, nanotechnology, and xenobiotics. It also discusses the potential of astaxanthin in chemoprevention and chemotherapeutic applications, and as a biomarker for liver function and enzymatic activity. Clinical trials and drug development of astaxanthin are also explored, along with its therapeutic potential in addressing hepatic steatosis and non-alcoholic fatty liver disease (NAFLD). Overall, this book is a valuable resource for researchers, clinicians, and students interested in the use of astaxanthin in the prevention and treatment of liver cancer.